Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients

References

• Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31S–8S.
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. Oxidized low-density lipoprotein. Methods Mol Biol 2010;610:403–17.
   PubMedGoogle Scholar
• Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ, Rozek MM. Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus. Diabetes Care 1992;15:1156–67.
   PubMed Web of Science ®Google Scholar
• Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995–8.
   PubMed Web of Science ®Google Scholar
• Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. Jama 2008;299:2287–93.
   PubMed Web of Science ®Google Scholar
• Nakhjavani M, Esteghamati A, Asgarani F, Khalilzadeh O, Nikzamir A, Safari R. Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study. Transl Res 2009;153:86–90. Epub 2008 Dec 9.
   PubMed Web of Science ®Google Scholar
• Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS. Leptin in human physiology and therapeutics. Front Neuroendocrinol 2010;31:377–93. Epub 2010 Jun 17.
   PubMed Web of Science ®Google Scholar
• Lam QL, Lu L. Role of leptin in immunity. Cell Mol Immunol 2007;4:1–13.
   PubMed Web of Science ®Google Scholar
• Beltowski J, Wojcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 2003;170:21–9.
   PubMed Web of Science ®Google Scholar
• Kaur S, Zilmer K, Leping V, Zilmer M. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. J Eur Acad Dermatol Venereol 2011;1111:1468–3083.
   Google Scholar
• Konstantinidis D, Paletas K, Koliakos G, Kaloyianni M. Signaling components involved in leptin-induced amplification of the atherosclerosis-related properties of human monocytes. J Vasc Res 2009;46:199–208. Epub 2008 Oct 9.
   PubMed Web of Science ®Google Scholar
• Porreca E, Di Febbo C, Moretta V, Angelini A, Guglielmi MD, Di Nisio M, et al. Circulating leptin is associated with oxidized LDL in postmenopausal women. Atherosclerosis 2004;175:139–43.
   PubMed Web of Science ®Google Scholar
• Njajou OT, Kanaya AM, Holvoet P, Connelly S, Strotmeyer ES, Harris TB, et al. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes Metab Res Rev 2009;25:733–9.
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Chowdhury S, Bhattacharyya M. Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Res Clin Pract 2011;93:56–62.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32 (Suppl 1):S62–7.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.
   PubMed Web of Science ®Google Scholar
• Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 2009;43:157–68.
   PubMedGoogle Scholar
• Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C, et al. Role of leptin in the activation of immune cells. Mediators Inflamm 2010;23. DOI: 10.1155/2010/568343.
   Google Scholar
• Cheung CC, Clifton DK, Steiner RA. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489–92.
   PubMed Web of Science ®Google Scholar
• Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 2006;116:1776–83.
   PubMed Web of Science ®Google Scholar
• Sarigianni M, Bekiari E, Tsapas A, Kaloyianni M, Koliakos G, Paletas K. Effect of leptin and insulin resistance on properties of human monocytes in lean and obese healthy participants. Angiology 2010;61:768–74. Epub 2010 May 12.
   PubMed Web of Science ®Google Scholar
• Stringer DM, Sellers EA, Burr LL, Taylor CG. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in first Nation youth with obesity or type 2 diabetes mellitus. Pediatr Diabetes 2009;10:269–77. Epub 2008 Oct 19.
   PubMed Web of Science ®Google Scholar
• Kassi E, Dalamaga M, Hroussalas G, Kazanis K, Merantzi G, Zachari A, et al. Adipocyte factors, high-sensitive C-reactive protein levels and lipoxidative stress products in overweight postmenopausal women with normal and impaired OGTT. Maturitas 2010;67:72–7. Epub 2010 Jun 8.
   PubMed Web of Science ®Google Scholar
• Demirel F, Bideci A, Cinaz P, Camurdan MO, Biberoglu G, Yesilkaya E, et al. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007;67:129–34. Epub 2007 Apr 25.
   PubMed Web of Science ®Google Scholar
• Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897–901.
   PubMed Web of Science ®Google Scholar
• Pamuk GE, Demir M, Harmandar F, Yesil Y, Turgut B, Vural O. Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics. Exp Oncol 2006;28:241–4.
   PubMedGoogle Scholar
• Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. J Immunol 2002;168:4018–24.
   PubMed Web of Science ®Google Scholar
• Gruver AL, Sempowski GD. Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol 2008;84:915–23. Epub 2008 May 21.
   PubMed Web of Science ®Google Scholar
• Papaevangelou V, Papassotiriou I, Vounatsou M, Chrousos G, Theodoridou M. Changes in leptin serum levels in HIV-infected children receiving highly active antiretroviral therapy. Scand J Clin Lab Invest 2007;67:291–6.
   PubMed Web of Science ®Google Scholar
• Paz-Filho GJ, Delibasi T, Erol HK, Wong ML, Licinio J. Cellular immunity before and after leptin replacement therapy. J Pediatr Endocrinol Metab 2009;22:1069–74.
   PubMed Web of Science ®Google Scholar
• Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540–3.
   PubMed Web of Science ®Google Scholar
• Sainz N, Rodriguez A, Catalan V, Becerril S, Ramirez B, Gomez-Ambrosi J, et al. Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice. Mediators Inflamm 2010;30. DOI: 10.1155/2010/784343.
   Google Scholar
• Vernooy JH, Bracke KR, Drummen NE, Pauwels NS, Zabeau L, van Suylen RJ, et al. Leptin modulates innate and adaptive immune cell recruitment after cigarette smoke exposure in mice. J Immunol 2010;184:7169–77. Epub 2010 May 19.
   PubMed Web of Science ®Google Scholar
• Clement K, Lahlou N, Ruiz J, Hager J, Bougneres P, Basdevant A, et al. Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes Relat Metab Disord 1997;21:556–61.
   PubMed Web of Science ®Google Scholar
• Passaro A, Calzoni F, Zamboni PF, Manservigi D, Alberti L, Dalla Nora E, et al. Role of diabetes in influencing leptin concentration in elderly overweight patients. Eur J Endocrinol 2001;145:173–9.
   PubMed Web of Science ®Google Scholar
• Marita AR, Sarkar JA, Rane S. Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India. Mol Cell Biochem 2005;275:143–51.
   PubMed Web of Science ®Google Scholar
• Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS, et al. Leptin and body fat in type 2 diabetes and monodrug therapy. J Clin Endocrinol Metab 2003;88:1543–53.
   PubMed Web of Science ®Google Scholar
• Scholze A, Rattensperger D, Zidek W, Tepel M. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring) 2007;15:1617–22.
   PubMed Web of Science ®Google Scholar
• Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 2001;59:1114–20.
   PubMed Web of Science ®Google Scholar
• Ozata M, Gungor D, Turan M, Ozisik G, Bingol N, Ozgurtas T, et al. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects. J Clin Endocrinol Metab 2001;86:3659–64.
   PubMed Web of Science ®Google Scholar
• Nar A, Gedik O. The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. Acta Diabetol 2009;46:113–8. Epub 2008 Oct 7.
   PubMed Web of Science ®Google Scholar
• Kanaley JA, Fenicchia LM, Miller CS, Ploutz-Synder LL, Weinstock RS, Carhart R, et al. Resting leptin responses to acute and chronic resistance training in type 2 diabetic men and women. Int J Obes Relat Metab Disord 2001;25:1474–80.
   PubMed Web of Science ®Google Scholar
• Wasim H, Al-Daghri NM, Chetty R, McTernan PG, Barnett AH, Kumar S. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol 2006;5:10.
   PubMedGoogle Scholar
• Morin-Papunen LC, Koivunen RM, Tomas C, Ruokonen A, Martikainen HK. Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2566–8.
   PubMed Web of Science ®Google Scholar
• Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996;81:4059–67.
   PubMed Web of Science ®Google Scholar
• Wright E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract 2006;60:308–14.
   PubMed Web of Science ®Google Scholar
• Erguder IB, Karagenc N, Karaca L. Reduced antioxidant potential & sensitivity to oxidation in plasma low density lipoprotein fraction in type 2 diabetes mellitus patients. Indian J Med Res 2006;124:207–10.
   PubMed Web of Science ®Google Scholar
• Rifici VA, Schneider SH, Khachadurian AK. Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis 1994;107:99–108.
   PubMed Web of Science ®Google Scholar
• Carantoni M, Abbasi F, Warmerdam F, Klebanov M, Wang PW, Chen YD, et al. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol 1998;18:762–7.
   PubMed Web of Science ®Google Scholar
• Kanigur-Sultuybek G, Ozdas SB, Curgunlu A, Tezcan V, Onaran I. Does metformin prevent short-term oxidant-induced dna damage? In vitro study on lymphocytes from aged subjects. J Basic Clin Physiol Pharmacol 2007;18:129–40.
   PubMedGoogle Scholar
• Correia S, Carvalho C, Santos MS, Proenca T, Nunes E, Duarte AI, et al. Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Med Chem 2008;4:358–64.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, Kamata K. Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol 2008;295:H1165–76. Epub 2008 Jul 18.
   PubMed Web of Science ®Google Scholar
• Xie W, Zhang SD, Ou XP, Yang TL. Protective effects of metformin on low-density lipoprotein-induced endothelial dysfunction in rats. Nan Fang Yi Ke Da Xue Xue Bao 2009;29:890–3.
   PubMedGoogle Scholar
• Formoso G, De Filippis EA, Michetti N, Di Fulvio P, Pandolfi A, Bucciarelli T, et al. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects. Diabetes Metab Res Rev 2008;24:231–7.
   PubMed Web of Science ®Google Scholar
• Rabbani N, Chittari MV, Bodmer CW, Zehnder D, Ceriello A, Thornalley PJ. Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. Diabetes 2010;59:1038–45.
   PubMed Web of Science ®Google Scholar
• Iida KT, Kawakami Y, Suzuki M, Shimano H, Toyoshima H, Sone H, et al. Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats. Am J Physiol Endocrinol Metab 2003;284:E1125–30.
   PubMed Web of Science ®Google Scholar
• Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167–74.
   PubMed Web of Science ®Google Scholar
• Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006;25:6680–4.
   PubMed Web of Science ®Google Scholar
• Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49–62.
   PubMed Web of Science ®Google Scholar
• Arai M, Uchiba M, Komura H, Mizuochi Y, Harada N, Okajima K. Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J Pharmacol Exp Ther 2010;334:206–13.
   PubMed Web of Science ®Google Scholar
• Vasconcelos EM, Degasperi GR, de Oliveira HC, Vercesi AE, de Faria EC, Castilho LN. Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin Biochem 2009;42:1222–7.
   PubMed Web of Science ®Google Scholar